Novo's Clayton facility makes semaglutide, the active ingredient in Wegovy and diabetes drug Ozempic. It also does ...

Novo Nordisk has cut dozens of jobs at its Clayton, North Carolina site, part of a global restructuring as it faces slowing ...

Novo Nordisk, the maker of weight loss drug Wegovy, will lay off about 9,000 people as it grapples with rising competition in the obesity market. The Danish company has been battling it out with US ...

Centrally acting agents like phentermine/topiramate and naltrexone/bupropion aid weight reduction but lack MASLD-specific ...

Tirzepatide should be the first-line choice for patients with obstructive sleep apnea, for which it holds an indication, and semaglutide should be the first choice for those with knee osteoarthritis, ...

As the demand for affordable healthcare options grows, the pharmaceutical industry is increasingly focused on developing generic drugs to expand access and reduce costs. This trend is driving major ...

Novo Nordisk research has explored how GLP-1 medications like Wegovy can quieten food noise, resulting in a healthier ...